Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba

Go back to Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba
(NASDAQ: DNLI) Delayed: 20.47 +0.75 (3.80%)
Previous Close $19.72    52 Week High
Open $19.99    52 Week Low
Day High $20.55    P/E N/A 
Day Low $19.40    EPS
Volume 2,393,794